DGCI
- India
Fake medicines: After WHO alerts, DGCI asks states to hold strict vigil
New Delhi: The Drugs Controller General of India (DCGI) has directed the drugs controllers of all states and Union territories to keep a strict vigil on the sale and distribution of falsified…
- India
Abbott recalls antacid Digene gel, DGCI issues alert
Leading American multinational medical devices and health care company, Abbott voluntarily recalled its antacid Digene gel after the Drugs Control General of India (DCGI) received a complaint on 9 August, alleging bitter…
- World
Dont use propylene glycol supplied by Delhi firm, orders DGCI post cough syrup deaths
New Delhi: India’s drug regulator has directed drug manufacturers not to use propylene glycol supplied by a Delhi-based company which provided the ingredient to Marion Biotech, whose cough syrups were alleged to…
- India
Bharat Biotech’s intranasal COVID vaccine approved by govt, to be available on CO-WIN
New Delhi: Bharat Biotech’s intranasal Covid vaccine has been approved by the Union Health Ministry for inclusion in the vaccination programme as a booster dose for those above 18 years of age,…
- India
Regular market approval granted for Covishield, Covaxin for use in adult population
New Delhi: India’s drug regulator on Thursday granted regular market approval for COVID-19 vaccines Covishield and Covaxin for use in the adult population subject to certain conditions, official sources said. The approval…
- India
DCGI to review applications of Bharat Biotech, SII for full market approval to Covaxin, Covishield today
New Delhi: Drugs Controller General of India (DCGI)’s Subject Expert Committee will review applications of Bharat Biotech and Serum Institute of India (SII) for full market approval to Covaxin and Covishield respectively…
- India
DGCI approves for phase III trial of Bharat Biotech intranasal vaccine as booster
New Delhi: The Subject Experts Committee (SEC) of the Drug Controller General of India (DGCI) on Wednesday granted “in principle” approval to Bharat Biotech to conduct “Phase III superiority study and Phase…